FDA says The Real Cost campaign stopped nearly 600,000 from smoking
Its research suggests the push could also help turn the tide against vaping.
Policy
Our neighbor to the north wants nothing to do with U.S. drug prices
As U.S. leaders work to bring down soaring drug costs, Canada is distancing itself.
Debate prep: What top Democrats have been saying about healthcare before round 2
Healthcare and drug prices are among the most-talked-about issues in this election and are bound to be discussed at this week’s debates.
Senate Finance Committee draws up comprehensive drug price bill
“This legislation shows that no industry is above accountability,” said Senators Chuck Grassley and Ron Wyden.
Trump’s price-disclosure rule is DOA, but not idea to include costs in EHRs
EHRs may be a viable channel for stimulating patient-doctor dialogue about the cost of care, say researchers and agencies.
Running out the clock: Lawsuit tries to delay TV drug price rule
The court is going down to the wire to decide a motion to delay the rule.
FDA clears the air around vape product marketing
The latest guidance on e-cigarettes is a culmination of the FDA’s and former commissioner Scott Gottlieb’s mission to regulate the industry.
How the healthcare industry wants the FDA to regulate cannabis products
The Food and Drug Administration is seeking comments on cannabis-derived products, including CBD.
Report: Trump administration plans executive order on healthcare cost transparency
The executive order would require healthcare companies to make prices public.
FDA after Gottlieb: Sharpless expected to push predecessor’s agenda during transition
The Senate may not take up a confirmation vote before the 2020 election, but one Beltway insider predicts the FDA will still be potent during the transition to a new commissioner.
